-
Latest News
- Introducing WAMES volunteers: Jan Russell
- Specifics of CFS coping strategies identified in a French flash survey during the COVID-19 containment
- Insights into metabolite diagnostic biomarkers for ME/CFS
- WAMES is growing to meet the challenges of 2021
- New study shows reduced ability to regulation of the cardiovascular system in patients with ME/CFS
Archives
Tag Archives: pharmacogenomics
Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
Treatment avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a split-gender pharmacogenomic study of gene-expression modules, by Mary G Jeffrey, Lubov Nathanson, Kristina Aenlle, Zachary M Barnes, Mirza Baig, Gordon Broderick, Nancy G Klimas, Mary Ann Fletcher, Travis JA Craddock in Clinical … Continue reading →
Posted in News
|
Tagged bioinformatics, Dr Nancy Klimas, drug repositioning, Gordon Broderick, immune dysregulation, immunosuppressants, Kistina Aenlle, Lubov Nathanson, Mary Ann Fletcher, Mary G Jeffrey, Mirza Baig, pharmacogenomics, Travis JA Craddock, treatments, Zachary Barnes
|
Comments Off on Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
